Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.
Now, ENvue said it expects to make its new syringes available through online retailers like Amazon. It also plans to launch ...
ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for ...
Pharmaceutical Technology on MSN
BD invests $110m to expand US prefillable syringe production
BD (Becton, Dickinson and Company) has announced a $110m investment to expand its production of prefillable syringes in the ...
The field of cancer immunotherapy has achieved remarkable progress, introducing strategies such as immune checkpoint inhibitors and adoptive cell therapies ...
West Pharmaceutical Services (NYSE:WST) announced that it reached an agreement to sell on-body drug delivery technology to ...
With a myriad of health effects, thyme extract may seem like a magic medicinal ingredient. Its biologically active ...
Johnson & Johnson gained Inlexzo, formerly known as TAR-200, when it acquired privately held Taris Biomedical in 2019. The deal gave J&J a treatment it says could change way the “non-muscle invasive” ...
Abstract: Although the generative novel view synthesis frameworks have already achieved the generation of target views from specific viewpoints, they still rely on either direct or indirect input of ...
NVIDIA remains a top semiconductor pick as AI-driven compute demand accelerates, while Amtech Systems emerges as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback